Johnson & Johnson
JNJJohnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 Fortune 500 list of the largest United States corporations. In 2024, the company was ranked 45th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.
Drugs in Pipeline
160
Phase 3 Programs
108
Upcoming Catalysts
1
Next Catalyst
Jun 30, 2026
13wMarket Overview
Stock performance and key metrics
1 upcoming, 1 past
Tapentadol (CG5503) Extended Release (ER)
Pain
Docetaxel
Breast Cancer
norelgestromin + ethinyl estradiol; triphasil.
Contraception
doripenum
Urinary Tract Infections
acetaminophen extended release
Osteoarthritis
CG5503
Diabetic Neuropathy
Duragesic® (fentanyl) Therapeutic Transdermal System (TTS)
Chronic Pain
CG5503 IR; tapentadol
Osteoarthritis
tramadol, acetaminophen
Diabetic Neuropathies
5% Minoxidil
Alopecia
naproxen
Osteoarthritis, Hip
risperidone; quetiapine
Bipolar Disorder
minoxidil
Androgenetic Alopecia
PDE5I (phosphodiesterase-5 inhibitor)
Erectile Dysfunction
Extended Release OROS® Paliperidone
Schizophrenia
acetaminophen Tablet
Post Operative Dental Pain
Paliperidone
Schizophrenia
Tipifarnib;Zarnestra; R115777
Acute Myeloid Leukemia
Epoetin alfa 3 times weekly /once weekly
Anemia
epoetin alfa
Chronic Kidney Disease
Risperidone long-acting injectable
Schizophrenia
Prucalopride
Constipation
topiramate, propranolol
Migraine
Ibrutinib
Leukemia, Lymphocytic, Chronic, B-Cell
TAR-200
Non-Muscle Invasive Bladder Neoplasms
Levetiracetam
Epilepsy
Cilta-cel
Multiple Myeloma
TMC435
Hepatitis C
Risperidone Long-acting Injectable (LAI) 25 mg
Schizophrenia
Tramadol Hydrochloride (HCL) plus Acetaminophen (JNS013)
Chronic Pain
JNJ-77242113
Plaque Psoriasis
Simeprevir
Hepatitis C Virus Infection
Fentanyl
Postherpetic Neuralgia
No treatment
Hepatitis C
JNJ-63723283
Multiple Myeloma
Guselkumab
Psoriasis
Daratumumab
Multiple Myeloma
Fulranumab 1 mg
Osteoarthritis
Ad26.COV2.S
Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol
Macitentan
Pulmonary Arterial Hypertension
Sirukumab 100 mg
Arthritis, Rheumatoid
Seltorexant
Depressive Disorder, Major
Ustekinumab
Crohn Disease
Teclistamab
Multiple Myeloma
Ustekinumab 90 mg SC q8w
Crohn's Disease
Group 1: Epoetin alfa
Myelodysplastic Syndromes
Lazertinib
Carcinoma, Non-Small-Cell Lung
PP6M
Schizophrenia
Etravirine
HIV Infections
Tapentadol (CG5503)
Arthralgia
Quetiapine
Bipolar Disorder
Durogesic® (fentanyl transdermal drug delivery system)
Chronic Pain
galantamine ER
Alzheimer's Disease
Test acetaminophen
Post-operative Dental Pain
risperidone oral tablets
Anxiety Disorders
Doxorubicin
Sarcoma
CG 5503;tapentadol
Osteoarthritis
tapentadol (CG5503) ER
Low Back Pain
levofloxacin
Pneumonia
Rivaroxaban
Atrial Fibrillation
tapentadol (CG5503) Immediate Release IR
Low Back Pain
levofloxacin, azithromycin, amoxicillin/clavulanate
Bronchitis
Acetaminophen/Naproxen Sodium Fixed Combination
Pain
Bortezomib
Multiple Myeloma
Paliperidone extended-release
Bipolar Disorder
Risperdal Consta
Bipolar Disorder
Vincristine, DOXIL (doxorubicin HCl liposomal injection), and Dexamethasone (VDD) vs. Vincristine, Doxorubicin and Dexamethasone (VAD)
Multiple Myeloma
paliperidone ER Oros
Schizophrenia
Gemcitabine with R115777
Pancreatic Neoplasms
Mebendazole
Healthy Volunteers
Dapoxetine
Erectile Dysfunction
F# 13418-148 Eye Drops
Ophthalmic Solutions
Rivaroxaban 2.5 mg
Acute Coronary Syndrome
Dexamethasone
Endometrial Neoplasms
levofloxacin; amoxicillin/clavulanate
Otitis Media
Paliperidone ER
Schizophrenia
topiramate
Essential Tremor
doripenem
Pneumonia
Trabectedin
Ovarian Cancer
risperidone
Bipolar Disorders
norelgestromin + ethinyl estradiol
Contraception
Rabeprazole sodium 5 mg
Gastroesophageal Reflux
Tapentadol extended release (ER)
Diabetic Peripheral Neuropathy
Oxycodone CR
Osteoarthritis, Hip
oxycodone IR
Joint Diseases
Thalidomide
Multiple Myeloma
oxycodone
Osteoarthritis, Knee
CG5503 IR;tapentadol
Arthralgia
Topiramate; Carbamazepine; Valproate
Epilepsy
levofloxacin; imipenem/cilastitin
Nosocomial Pneumonia
Pancrease MT 10.5, or MT 21
Exocrine Pancreatic Insufficiency
Colloidal Oatmeal Cream
Eczema
ivermectin
Lice Infestations
Paliperidone palmitate 25 mg eq.
Schizophrenia
JNJ-90301900 (NBTXR3)
Locally Advanced Head and Neck Squamous Cell Carcinoma
norelgestromin + ethinyl estradiol; mercilon
Contraception
Extended-release galantamine hydrobromide
Schizophrenia
acetaminophen
Osteoarthritis of the Knee
Olanzapine
Bipolar Disorder
Test naproxen sodium tablet
Post-operative Dental Pain
galantamine
Alzheimer's Disease
5% Minoxidil Topical Foam
Androgenetic Alopecia
Imonogas
Functional Dyspepsia
rabeprazole
Gastroesophageal Reflux Disease (GERD)
galantamine hydrobromide
Alzheimer Disease
Hydromorphone HCl
Pain
topiramate, phenytoin
Epilepsy
Paliperidone palmitate
Schizophrenia
R228060
Major Depressive Disorder
Investigational Lubricating Eye Drop in a Novelia® bottle
Dry Eye
JNJ 40929837
Asthma
JNJ-39220675
Allergic Rhinitis
R209130
Schizophrenia
Abiraterone acetate
Prostate Neoplasms
JNJ-90301900
Carcinoma, Non-Small-Cell Lung
Experimental Product 1% Colloidal Oatmeal Balm
Atopic Dermatitis
Yondelis
Liposarcoma
JNJ16269110
Diabetes Mellitus, Type 2
Decitabine
Myelodysplastic Syndrome
ibuprofen; pseudoephedrine HCl
Enuresis
ET743
Breast Neoplasms
R256918
Obesity
Amivantamab
Carcinoma, Non-Small-Cell Lung
ZARNESTRA, tipifarnib, R115777
Acute Myeloid Leukemia
Canagliflozin 50 mg
Diabetes Mellitus, Type 2
Apalutamide
Salivary Gland Neoplasms
VX-787 300 mg
Influenza A
JNJ-73763989
Hepatitis B, Chronic
JNJ-17166864
Allergic Rhinitis
tapentadol HCl
Pain
Acetaminophen (ACE) (1000 mg)
Dental Pain
Ad26.Mos.HIV
Healthy
JNJ-37822681
Schizophrenia
Escitalopram
Major Depressive Disorder
Canagliflozin (JNJ-28431754)
Diabetes Mellitus, Type II
RWJ-445380 100 mg
Rheumatoid Arthritis
Acetaminophen/naproxen sodium Dose A
Pain
PROCRIT (Epoetin alfa)
Anemia
NNC0142-0002
Inflammation
R092670
Schizophrenia
RSV Vaccine
Healthy
Olomorasib
Carcinoma, Non-Small-Cell Lung
Ad26.RSV.preF
Respiratory Syncytial Virus
Tapentadol
Pain
Rilpivirine
HIV-1
JNJ-41443532
Diabetes Mellitus, Type 2
Blink® Tears eye drops in a multidose bottle
Visual Acuity
Dupilumab
Dermatitis, Atopic
Abiraterone
Prostate Cancer
JNJ-39588146 5 ng/kg/min
Heart Failure
tipifarnib (R115777)
Leukemia, Nonlymphocytic, Acute
JNJ39758979
Asthma
Talquetamab
Multiple Myeloma
Erdafitinib
Advanced Solid Tumor
440 mg naproxen sodium with 1000 mg acetaminophen
Pain
JNJ-26489112
Photosensitive Epilepsy
Imipenem/cilastatin
Pneumonia, Ventilator-Associated
JNJ-31001074
Attention Deficit Hyperactivity Disorder
Atomoxetine 80 mg/d
Attention Deficit Hyperactivity Disorder
Lenalidomide
Lymphoma, Mantle-Cell
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tapentadol (CG5503) Extended Release (ER) | Phase 3 | Pain | - | - |
Docetaxel | Phase 3 | Breast Cancer | - | - |
norelgestromin + ethinyl estradiol; triphasil. | Phase 3 | Contraception | - | - |
doripenum | Phase 3 | Urinary Tract Infections | - | - |
acetaminophen extended release | Phase 3 | Osteoarthritis | - | - |
CG5503 | Phase 3 | Diabetic Neuropathy | - | - |
Duragesic® (fentanyl) Therapeutic Transdermal System (TTS) | Phase 3 | Chronic Pain | - | - |
CG5503 IR; tapentadol | Phase 3 | Osteoarthritis | - | - |
tramadol, acetaminophen | Phase 3 | Diabetic Neuropathies | - | - |
5% Minoxidil | Phase 3 | Alopecia | - | - |
naproxen | Phase 3 | Osteoarthritis, Hip | - | - |
risperidone; quetiapine | Phase 3 | Bipolar Disorder | - | - |
minoxidil | Phase 3 | Androgenetic Alopecia | - | - |
PDE5I (phosphodiesterase-5 inhibitor) | Phase 3 | Erectile Dysfunction | - | - |
Extended Release OROS® Paliperidone | Phase 3 | Schizophrenia | - | - |
acetaminophen Tablet | Phase 3 | Post Operative Dental Pain | - | - |
Paliperidone | Phase 3 | Schizophrenia | - | - |
Tipifarnib;Zarnestra; R115777 | Phase 3 | Acute Myeloid Leukemia | - | - |
Epoetin alfa 3 times weekly /once weekly | Phase 3 | Anemia | - | - |
epoetin alfa | Phase 3 | Chronic Kidney Disease | - | - |
Risperidone long-acting injectable | Phase 3 | Schizophrenia | - | - |
Prucalopride | Phase 3 | Constipation | - | - |
topiramate, propranolol | Phase 3 | Migraine | - | - |
Ibrutinib | Phase 3 | Leukemia, Lymphocytic, Chronic, B-Cell | - | - |
TAR-200 | Phase 3 | Non-Muscle Invasive Bladder Neoplasms | - | - |
Levetiracetam | Phase 3 | Epilepsy | - | - |
Cilta-cel | Phase 3 | Multiple Myeloma | - | - |
TMC435 | Phase 3 | Hepatitis C | - | - |
Risperidone Long-acting Injectable (LAI) 25 mg | Phase 3 | Schizophrenia | - | - |
Tramadol Hydrochloride (HCL) plus Acetaminophen (JNS013) | Phase 3 | Chronic Pain | - | - |
JNJ-77242113 | Phase 3 | Plaque Psoriasis | - | - |
Simeprevir | Phase 3 | Hepatitis C Virus Infection | - | - |
Fentanyl | Phase 3 | Postherpetic Neuralgia | - | - |
No treatment | Phase 3 | Hepatitis C | - | - |
JNJ-63723283 | Phase 3 | Multiple Myeloma | - | - |
Guselkumab | Phase 3 | Psoriasis | - | - |
Daratumumab | Phase 3 | Multiple Myeloma | - | - |
Fulranumab 1 mg | Phase 3 | Osteoarthritis | - | - |
Ad26.COV2.S | Phase 3 | Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol | - | - |
Macitentan | Phase 3 | Pulmonary Arterial Hypertension | - | - |
Sirukumab 100 mg | Phase 3 | Arthritis, Rheumatoid | - | - |
Seltorexant | Phase 3 | Depressive Disorder, Major | - | - |
Ustekinumab | Phase 3 | Crohn Disease | - | - |
Teclistamab | Phase 3 | Multiple Myeloma | - | - |
Ustekinumab 90 mg SC q8w | Phase 3 | Crohn's Disease | - | - |
Group 1: Epoetin alfa | Phase 3 | Myelodysplastic Syndromes | - | - |
Lazertinib | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
PP6M | Phase 3 | Schizophrenia | - | - |
Etravirine | Phase 3 | HIV Infections | - | - |
Tapentadol (CG5503) | Phase 3 | Arthralgia | - | - |
Quetiapine | Phase 3 | Bipolar Disorder | - | - |
Durogesic® (fentanyl transdermal drug delivery system) | Phase 3 | Chronic Pain | - | - |
galantamine ER | Phase 3 | Alzheimer's Disease | - | - |
Test acetaminophen | Phase 3 | Post-operative Dental Pain | - | Patent 2032 |
risperidone oral tablets | Phase 3 | Anxiety Disorders | - | - |
Doxorubicin | Phase 3 | Sarcoma | - | - |
CG 5503;tapentadol | Phase 3 | Osteoarthritis | - | - |
tapentadol (CG5503) ER | Phase 3 | Low Back Pain | - | - |
levofloxacin | Phase 3 | Pneumonia | - | |
Rivaroxaban | Phase 3 | Atrial Fibrillation | - | Patent 2034 |
tapentadol (CG5503) Immediate Release IR | Phase 3 | Low Back Pain | - | - |
levofloxacin, azithromycin, amoxicillin/clavulanate | Phase 3 | Bronchitis | - | - |
Acetaminophen/Naproxen Sodium Fixed Combination | Phase 3 | Pain | - | - |
Bortezomib | Phase 3 | Multiple Myeloma | - | Patent 2042 |
Paliperidone extended-release | Phase 3 | Bipolar Disorder | - | - |
Risperdal Consta | Phase 3 | Bipolar Disorder | - | - |
Vincristine, DOXIL (doxorubicin HCl liposomal injection), and Dexamethasone (VDD) vs. Vincristine, Doxorubicin and Dexamethasone (VAD) | Phase 3 | Multiple Myeloma | - | - |
paliperidone ER Oros | Phase 3 | Schizophrenia | - | |
Gemcitabine with R115777 | Phase 3 | Pancreatic Neoplasms | - | - |
Mebendazole | Phase 3 | Healthy Volunteers | - | |
Dapoxetine | Phase 3 | Erectile Dysfunction | - | - |
F# 13418-148 Eye Drops | Phase 3 | Ophthalmic Solutions | - | - |
Rivaroxaban 2.5 mg | Phase 3 | Acute Coronary Syndrome | - | Patent 2034 |
Dexamethasone | Phase 3 | Endometrial Neoplasms | - | Patent 2041 |
levofloxacin; amoxicillin/clavulanate | Phase 3 | Otitis Media | - | - |
Paliperidone ER | Phase 3 | Schizophrenia | - | |
topiramate | Phase 3 | Essential Tremor | - | Patent 2040 |
doripenem | Phase 3 | Pneumonia | - | |
Trabectedin | Phase 3 | Ovarian Cancer | - | Patent 2028 |
risperidone | Phase 3 | Bipolar Disorders | - | Patent 2042 |
norelgestromin + ethinyl estradiol | Phase 3 | Contraception | - | - |
Rabeprazole sodium 5 mg | Phase 3 | Gastroesophageal Reflux | - | |
Tapentadol extended release (ER) | Phase 3 | Diabetic Peripheral Neuropathy | - | - |
Oxycodone CR | Phase 3 | Osteoarthritis, Hip | - | Patent 2036 |
oxycodone IR | Phase 3 | Joint Diseases | - | - |
Thalidomide | Phase 3 | Multiple Myeloma | - | - |
oxycodone | Phase 3 | Osteoarthritis, Knee | - | - |
CG5503 IR;tapentadol | Phase 3 | Arthralgia | - | - |
Topiramate; Carbamazepine; Valproate | Phase 3 | Epilepsy | - | - |
levofloxacin; imipenem/cilastitin | Phase 3 | Nosocomial Pneumonia | - | - |
Pancrease MT 10.5, or MT 21 | Phase 3 | Exocrine Pancreatic Insufficiency | - | - |
Colloidal Oatmeal Cream | Phase 3 | Eczema | - | - |
ivermectin | Phase 3 | Lice Infestations | - | - |
Paliperidone palmitate 25 mg eq. | Phase 3 | Schizophrenia | - | - |
JNJ-90301900 (NBTXR3) | Phase 3 | Locally Advanced Head and Neck Squamous Cell Carcinoma | - | - |
norelgestromin + ethinyl estradiol; mercilon | Phase 3 | Contraception | - | - |
Extended-release galantamine hydrobromide | Phase 3 | Schizophrenia | - | - |
acetaminophen | Phase 3 | Osteoarthritis of the Knee | - | - |
Olanzapine | Phase 3 | Bipolar Disorder | - | - |
Test naproxen sodium tablet | Phase 3 | Post-operative Dental Pain | - | - |
galantamine | Phase 3 | Alzheimer's Disease | - | - |
5% Minoxidil Topical Foam | Phase 3 | Androgenetic Alopecia | - | - |
Imonogas | Phase 3 | Functional Dyspepsia | - | - |
rabeprazole | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
galantamine hydrobromide | Phase 3 | Alzheimer Disease | - | - |
Hydromorphone HCl | Phase 3 | Pain | - | - |
topiramate, phenytoin | Phase 3 | Epilepsy | - | - |
Paliperidone palmitate | Phase 3 | Schizophrenia | - | - |
R228060 | Phase 2 | Major Depressive Disorder | - | - |
Investigational Lubricating Eye Drop in a Novelia® bottle | Phase 2 | Dry Eye | - | - |
JNJ 40929837 | Phase 2 | Asthma | - | - |
JNJ-39220675 | Phase 2 | Allergic Rhinitis | - | - |
R209130 | Phase 2 | Schizophrenia | - | - |
Abiraterone acetate | Phase 2 | Prostate Neoplasms | - | - |
JNJ-90301900 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Experimental Product 1% Colloidal Oatmeal Balm | Phase 2 | Atopic Dermatitis | - | - |
Yondelis | Phase 2 | Liposarcoma | - | - |
JNJ16269110 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Decitabine | Phase 2 | Myelodysplastic Syndrome | - | - |
ibuprofen; pseudoephedrine HCl | Phase 2 | Enuresis | - | - |
ET743 | Phase 2 | Breast Neoplasms | - | - |
R256918 | Phase 2 | Obesity | - | - |
Amivantamab | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
ZARNESTRA, tipifarnib, R115777 | Phase 2 | Acute Myeloid Leukemia | - | - |
Canagliflozin 50 mg | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Apalutamide | Phase 2 | Salivary Gland Neoplasms | - | - |
VX-787 300 mg | Phase 2 | Influenza A | - | - |
JNJ-73763989 | Phase 2 | Hepatitis B, Chronic | - | - |
JNJ-17166864 | Phase 2 | Allergic Rhinitis | - | - |
tapentadol HCl | Phase 2 | Pain | - | - |
Acetaminophen (ACE) (1000 mg) | Phase 2 | Dental Pain | - | - |
Ad26.Mos.HIV | Phase 2 | Healthy | - | - |
JNJ-37822681 | Phase 2 | Schizophrenia | - | - |
Escitalopram | Phase 2 | Major Depressive Disorder | - | - |
Canagliflozin (JNJ-28431754) | Phase 2 | Diabetes Mellitus, Type II | - | - |
RWJ-445380 100 mg | Phase 2 | Rheumatoid Arthritis | - | - |
Acetaminophen/naproxen sodium Dose A | Phase 2 | Pain | - | - |
PROCRIT (Epoetin alfa) | Phase 2 | Anemia | - | - |
NNC0142-0002 | Phase 2 | Inflammation | - | - |
R092670 | Phase 2 | Schizophrenia | - | - |
RSV Vaccine | Phase 2 | Healthy | - | - |
Olomorasib | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Ad26.RSV.preF | Phase 2 | Respiratory Syncytial Virus | - | - |
Tapentadol | Phase 2 | Pain | - | - |
Rilpivirine | Phase 2 | HIV-1 | - | - |
JNJ-41443532 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Blink® Tears eye drops in a multidose bottle | Phase 2 | Visual Acuity | - | - |
Dupilumab | Phase 2 | Dermatitis, Atopic | - | - |
Abiraterone | Phase 2 | Prostate Cancer | - | - |
JNJ-39588146 5 ng/kg/min | Phase 2 | Heart Failure | - | - |
tipifarnib (R115777) | Phase 2 | Leukemia, Nonlymphocytic, Acute | - | - |
JNJ39758979 | Phase 2 | Asthma | - | - |
Talquetamab | Phase 2 | Multiple Myeloma | - | - |
Erdafitinib | Phase 2 | Advanced Solid Tumor | - | - |
440 mg naproxen sodium with 1000 mg acetaminophen | Phase 2 | Pain | - | - |
JNJ-26489112 | Phase 2 | Photosensitive Epilepsy | - | - |
Imipenem/cilastatin | Phase 2 | Pneumonia, Ventilator-Associated | - | - |
JNJ-31001074 | Phase 2 | Attention Deficit Hyperactivity Disorder | - | - |
Atomoxetine 80 mg/d | Phase 2 | Attention Deficit Hyperactivity Disorder | - | - |
Lenalidomide | Phase 2 | Lymphoma, Mantle-Cell | - | - |
Schizophrenia
4 drugs in this indication
Bipolar Disorder
3 drugs in this indication
Pneumonia
2 drugs in this indication
Pain
2 drugs in this indication
Diabetes Mellitus, Type 2
2 drugs in this indication
Multiple Myeloma
2 drugs in this indication
Low Back Pain
2 drugs in this indication
Post-operative Dental Pain
1 drug in this indication
Bronchitis
1 drug in this indication
Endometrial Neoplasms
1 drug in this indication
Anxiety Disorders
1 drug in this indication
Chronic Kidney Disease
1 drug in this indication
Healthy Volunteers
1 drug in this indication
Ophthalmic Solutions
1 drug in this indication
Ovarian Cancer
1 drug in this indication
Sarcoma
1 drug in this indication
Osteoarthritis
1 drug in this indication
Erectile Dysfunction
1 drug in this indication
Acute Coronary Syndrome
1 drug in this indication
Bipolar Disorders
1 drug in this indication
Atrial Fibrillation
1 drug in this indication
Otitis Media
1 drug in this indication
Contraception
1 drug in this indication
Alzheimer's Disease
1 drug in this indication
Carcinoma, Non-Small-Cell Lung
1 drug in this indication
Enuresis
1 drug in this indication
Pancreatic Neoplasms
1 drug in this indication
Gastroesophageal Reflux
1 drug in this indication
Major Depressive Disorder
1 drug in this indication
Atopic Dermatitis
1 drug in this indication
Essential Tremor
1 drug in this indication
Joint Diseases
1 drug in this indication
Sprains and Strains
1 drug in this indication
Diabetic Peripheral Neuropathy
1 drug in this indication
Heart Failure
1 drug in this indication
Osteoarthritis, Hip
1 drug in this indication
Leukemia, Nonlymphocytic, Acute
1 drug in this indication
Asthma
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)